Breaking News
October 16, 2018 - Study uncovers important role of PRMT1 in dilated cardiomyopathy
October 16, 2018 - Nutritional quality of breakfast linked to cardiovascular and metabolic risk factors in children
October 16, 2018 - Scientists develop dual anthrax-plague vaccine
October 16, 2018 - Poor Outcomes for Hispanic Infants With Congenital Heart Dz
October 16, 2018 - Global study finds youngest in class more likely to be diagnosed with ADHD
October 16, 2018 - Researchers sequence two selfish genes in the fungus Neurospora intermedia
October 16, 2018 - Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis
October 16, 2018 - Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration
October 16, 2018 - Researchers create open access database on healthy immunity
October 16, 2018 - Rice University chemist wins big award to study small surfaces
October 16, 2018 - Study finds 43% drop in stroke rate
October 16, 2018 - Researchers identify basic relationships of cell cycle and cellular senescence in the placenta
October 16, 2018 - Obesity Doubles Odds for Colon Cancer in Younger Women
October 16, 2018 - Adults with ADHD not constrained in creativity
October 16, 2018 - Raising visibility for people and students with chronic illness and disability
October 16, 2018 - Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis
October 16, 2018 - Only 59% of young adults undergoing surgery are fluid responsive
October 16, 2018 - Research points to potential new treatment for hearing loss
October 16, 2018 - MDI Biological Laboratory receives $1.2 million SEPA grant to promote data literacy
October 16, 2018 - Vast majority of dementia cases may arise from spontaneous genetic errors
October 16, 2018 - New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases
October 16, 2018 - Study identifies molecular switch that controls fate of milk-producing breast cells
October 16, 2018 - Research shows diet has little influence on precursor to gout
October 16, 2018 - “Without Dr. Shumway doing his miracle work, three generations would not be here”: A Stanford heart transplant patient’s story
October 16, 2018 - Non-invasive brain stimulation sheds light on neurobiology underlying implicit bias
October 16, 2018 - Researchers demonstrate integrated technique to control production of cell therapeutics
October 16, 2018 - Breast tomosynthesis detects 34% more tumors than traditional mammography
October 16, 2018 - Rhode Island Hospital, Brown receive $800,000 grant to keep up fight against opioid epidemic
October 16, 2018 - UVA partners with health systems in AVIA network’s Medicaid Transformation Project
October 16, 2018 - Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
October 16, 2018 - Study reveals early warning signs of heart problems in patients with newly diagnosed lupus
October 16, 2018 - Connecting the dots of Alzheimer’s disease
October 16, 2018 - New publication offers evidence-based content for global breast imaging medical community
October 16, 2018 - ‘EinsteinVision’ that improves hand-eye coordination of surgeons introduced at Harefield Hospital
October 16, 2018 - WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine
October 16, 2018 - Ketamine can be considered as alternative to opioids for short-term pain control in ED
October 16, 2018 - Endurance exercise training beneficially alters gut microbiota composition
October 15, 2018 - FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
October 15, 2018 - Birthing Options for Full-Term Pregnancy
October 15, 2018 - Stressed, toxic, zombie cells seen for first time in Alzheimer’s
October 15, 2018 - Concussion researchers study head motion in high school football hits | News Center
October 15, 2018 - Neuropsychiatric symptoms related to earliest stages of Alzheimer’s brain pathology
October 15, 2018 - Neck collar device may help protect the brain of female high school soccer players
October 15, 2018 - Research reveals how the inner ear processes speech
October 15, 2018 - Many parents still skeptical about safety and effectiveness of flu shot, survey finds
October 15, 2018 - Payer Policies May Discourage Non-Pharma Tx for Low Back Pain
October 15, 2018 - Exercise may delay cognitive decline in people with rare Alzheimer’s disease
October 15, 2018 - Researchers modify CRISPR to reorganize genome | News Center
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Study highlights need for increased support for alcohol-related liver disease patients
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Schiller Easy Pulse Saves Lives
October 15, 2018 - The latest ECG device from Schiller
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
October 15, 2018 - Engineering teratoma-derived fibroblasts to enhance osteogenesis
October 15, 2018 - Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism
October 15, 2018 - JCU study firms up association between diet and depression
October 15, 2018 - Researchers to study the use of CRISPR on human liver on-a-chip platform
October 15, 2018 - Sub-concussive impacts not associated with decline in neurocognitive function
October 15, 2018 - Researchers find potential treatment to halt premature labor and birth
October 15, 2018 - As U.S. suicides rates rise, Hispanics show relative immunity
October 15, 2018 - FDA Issues a Complete Response Letter to Acacia Pharma for Barhemsys
October 15, 2018 - Photoactive bacteria bait may help in fight against MRSA infections
Blood take a look at might expect medicine results for sufferers with localized NSCLC

Blood take a look at might expect medicine results for sufferers with localized NSCLC

image_pdfDownload PDFimage_print

A brand new learn about demonstrates blood take a look at to come across most cancers might expect medicine results for sufferers with localized non-small cellular lung most cancers (NSCLC) and come up with the money for physicians further lead time to personalize medicine for recurrent illness. Sufferers within the learn about with detectable ranges of circulating tumor DNA (ctDNA) in a while after medicine all had recurrences inside of two years, whilst all however one of the vital sufferers with out detectable ctDNA in a while after medicine remained disease-free and survived long-term. Typical imaging, conversely, was once no longer prognostic for recurrence or survival. Findings will probably be offered as of late on the 59th Annual Assembly of the American Society for Radiation Oncology (ASTRO).

The competitive nature of lung most cancers could make long-term control particularly difficult. As a result of NSCLC has a tendency to development, even following medicine, common tracking for recurrence is essential. The CT scans in most cases used for tracking, then again, are steadily not able to come across microscopic tumor deposits or to tell apart standard tissue adjustments led to via medicine from adjustments led to via recurrent illness.

“Blood exams that may come across minute lines of most cancers that stay after medicine may just make stronger recurrence tracking and probably be offering physicians months of extra lead time to tailor therapies and make stronger our sufferers’ results and high quality of lifestyles,” stated Aadel Chaudhuri, MD, PhD, lead writer of the learn about and a major resident in radiation oncology at Stanford College in Palo Alto, California.

“Our findings recommend that ctDNA research, in contrast to CT scans, can determine in a while after medicine of completion if a affected person with localized lung most cancers has most probably been cured via radiation or surgical operation or if she or he nonetheless has most cancers cells provide of their frame. Whilst we anticipated that ctDNA detection of molecular residual illness would expect deficient scientific results, we had been shocked via how strongly predictive the take a look at was once for recurrence and survival.”

Presence of ctDNA was once measured as a marker of molecular residual illness (MRD) in sufferers with degree I-III NSCLC instantly earlier than medicine and in a while after medicine was once finished. ctDNA ranges additionally had been measured mid-treatment (reasonable = Three weeks, vary = 1.Four-Three.7 weeks) for part of the sufferers receiving chemoradiation (n = 13 of 27 sufferers). Most cancers Customized Profiling via Deep Sequencing (CAPP-Seq) was once used to evaluate whether or not ctDNA was once provide. Surveillance scans the use of CT imaging had been evaluated the use of the Reaction Analysis Standards In Forged Tumors (RECIST).

The median affected person age was once 67 years (vary 47-91 years), and maximum sufferers (67%) had been male. All 41 sufferers had been handled with healing intent, together with with chemoradiation remedy (66%), radiation remedy on my own (27%) and surgical operation on my own (7%). Median follow-up for the learn about was once 35 months (vary 7-56 months).

Researchers detected ctDNA pretreatment in 38 of the 41 sufferers (93%). Thirty-four of those 38 sufferers had blood drawn inside of 4 months of medicine of completion (the prespecified MRD landmark) and had been eligible for next research.

A few of the 34 sufferers with ctDNA MRD pretreatment, greater than part (56%, n = 19) had detectable residual illness after medicine. All of those sufferers therefore evolved recurrent lung most cancers, in comparison with most effective one of the vital 15 sufferers with out detectable ctDNA MRD.

Sufferers with detectable ctDNA MRD after medicine had worse freedom from development and survival than sufferers with out detectable ctDNA MRD (freedom from development Danger Ratio (HR) =, p < zero.0001; disease-specific survival HR = 27.7, p < zero.0001). CT imaging on the identical time was once no longer prognostic for survival. ctDNA ranges earlier than medicine additionally weren't related to survival results.

In 8 of the 13 sufferers assessed mid-treatment, ctDNA accounted for zero.1 p.c or extra of all cell-free DNA. For those sufferers, mid-treatment ctDNA ranges predicted eventual illness development (HR = 2.7, p = zero.006). Sixty p.c of the sufferers with not up to zero.1 p.c ctDNA mid-treatment had been progression-free at two years following medicine, in comparison to not one of the sufferers with zero.1 p.c or upper ranges of ctDNA (HR = Four.Four, p = zero.037).

“Someday, clinicians could possibly use ctDNA research to spot sufferers who may just get pleasure from further medicine after first-line remedy,” stated Maximilian Diehn, MD, PhD, senior writer of the learn about and an assistant professor of radiation oncology at Stanford.

“In a similar learn about additionally offered at this yr’s ASTRO Annual Assembly, we discovered that ctDNA research detected illness recurrence a mean five.five months previous than standard-of-care CT imaging for localized lung most cancers and helped with interpretation of equivocal follow-up imaging. This implies that ctDNA research may just open a window to regard sufferers with residual most cancers early, whilst illness burden is minimum.”​

Tagged with:

About author

Related Articles